Sonic Healthcare Limited (SKHHY) Research
Headquartered in Sydney, Australia, Sonic Healthcare Limited, established in 1934, is a global provider of medical diagnostic and healthcare services. The company delivers a comprehensive range of laboratory medicine (pathology) services, alongside extensive diagnostic imaging and radiology capabilities, which include MRI, CT scans, ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. Beyond diagnostics, Sonic Healthcare also offers various primary care medical solutions. These encompass general practitioner services, occupational health support, remote healthcare provisions, community and in-home nursing, primary care research initiatives, health assessment technologies, clinical trial management, and chronic disease management programs. These crucial services are extended to medical professionals, hospitals, community health organizations, and their respective patients. Furthermore, the company provides administrative support and facilities to medical practitioners. Sonic Healthcare maintains a significant international presence, operating across Australia, New Zealand, the United Kingdom, the United States, Germany, Switzerland, Belgium, and Ireland.
Market snapshot
- Symbol
- SKHHY
- Price
- $13.87
- Day change
- -0.45%
- Market cap
- $9.9B
- P/E ratio
- 18.06x
- 52-week range
- 12.94-19.25
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Next earnings
- in 2 months
- Analyst price target
- $30.15
Peer companies
Open Sonic Healthcare Limited (SKHHY) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.